Posts tagged Oppenheimer

Nutanix Inc (NTNX) Named Top 2018 Pick At Oppenheimer

Nutanix gets another vote of confidence from Oppenheimer’s Ittai Kidron.

GoPro Inc (GPRO) Execution Is Not the Issue: Oppenheimer

Analyst has become more positive on GoPro’s new, impressive software; cautious only on sustainability.

DJI’s Spark Short Circuits Ambarella Inc (AMBA) Drone Revenue Leading to Weaker Outlook

Ambarella’s computer vision chips present enticing long-term possibilities, says Oppenheimer.

Palo Alto Networks Inc (PANW) New Product Development a Key to Continued Growth: Oppenheimer

Sales reorganization initiatives and improved execution levels are encouraging, says analyst.

Oppenheimer Comments on The Medicines Company (MDCO) Following FDA Approval for VABOMERE

The Medicines Company’s Vabomere – A Solid Option for CarbapenemResistant cUTIs: Oppenheimer

The Medicines Company (MDCO): Inclisiran Shows Momentum on Longer-Term Data, Oppenheimer Weighs in

Yesterday, at the European Society of Cardiology (ESC) Congress 2017 in Barcelona, The Medicines Company …